Brawn Biotech

Brawn Biotech Rule of 40

The Rule of 40 of Brawn Biotech (530207.BO) as of Oct 15, 2026 is -32.39 %. In the previous year, Rule of 40 was -35.64 % — a change of -9.12% (higher).

Rule of 40

-32.39 %

YoY

-9.12%

Last updated:

Rule of 40 of Brawn Biotech is 2025 -32.39 % . Rule of 40 of Brawn Biotech was 2024 -35.64 % . It decreases by -9.12% higher compared to the previous year.

The Brawn Biotech Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2024
-35.64 INR
Jan 1, 2025
-32.39 INR
The Brawn Biotech Rule of 40 history
YEARRule of 40YoY
-32.39 %-9.12%
-35.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Brawn Biotech Stock analysis

What does Brawn Biotech do? Brawn Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brawn Biotech stock

Rule of 40 of Brawn Biotech is -32.39 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Brawn Biotech since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — Brawn Biotech

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Brawn Biotech